0001209191-22-046962.txt : 20220819 0001209191-22-046962.hdr.sgml : 20220819 20220819214005 ACCESSION NUMBER: 0001209191-22-046962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220817 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kashmolah Ghazi CENTRAL INDEX KEY: 0001877741 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 221182029 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-17 0 0001652724 Lucira Health, Inc. LHDX 0001877741 Kashmolah Ghazi 1412 62ND STREET EMERYVILLE CA 94608 0 1 0 0 Ex VP & Chief Quality Officer Common Stock 2022-08-17 4 S 0 19074 2.83 D 180757 D Common Stock 2022-08-18 4 S 0 3500 2.25 D 177257 D These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares. Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022. /s/ Dan George, Attorney-in-Fact for Ghazi Kashmolah 2022-08-19